Recent Conference Abstracts
From the list of selected conference abstracts you can get an overview of current research topics:
ISPOR 2017 in Glasgow
AMNOG Dossiers as a Challenge for Pharmaceutical Companies
Application of Balancing Techniques in Studies Utilizing German Administrative Healthcare Data
Application of Mixed-Method Study Designs in Health-Economic-Related Studies
Application Study of the EQ-5D-5L in Oncology
Clinical Comparison of First-Line Platin Chemotherapy
Cost and Operational Efficiency Comparison of an Integrated vs. a Multi-Step System
German AMNOG Benefit Assessment
Non-quantifiable Benefit within the German AMNOG System
Overcoming the Limitations of Claims Data
Relevance of Real-world Data in German AMNOG Submissions in Oncology
Survival Differences in Heart Failure Patients
The Impact of Patient Preference Studies in the German Healthcare System
Transition from Orphan Drug to Full Assessment in the German AMNOG System
Utilization and Evaluation of Delphi Panels in German AMNOG Assessments
ISPOR 2016 in Vienna
Impact of Trial Design on Price Discounts after Early Benefit Assessment (AMNOG) in Germany
The Value of Patient Reported Outcomes in German AMNOG Dossiers
ISPOR 2015 in Milan
Real World Evidence (RWE) In Oncology – Status Quo In Germany
Incidence and Prevalence Estimations Based on Claims Data – New Methodological Considerations
ISPOR 2015 in Philadelphia
Use of Real-world Evidence in German AMNOG Applications
ISPOR 2014 in Amsterdam
AMNOG Benefit Assessment for Oncologic and Orphan Drugs in Germany: Implications for Price Discounts
Burden of Disease Caused by Influenza in Germany: A Retrospective Claims Database Analysis